Biosensor-based profiling to track cellular signalling in patient-derived models of dilated cardiomyopathy

Area of Science:

• Cardiovascular Research
• Cellular Signaling
• Regenerative Medicine

Background:

• Dilated cardiomyopathies (DCM) are heterogeneous cardiovascular diseases affecting myocardial structure and function.
• Understanding the impact of DCM on critical signaling pathways is crucial for developing effective therapeutic strategies.
• Advances in biosensor technology and human induced pluripotent stem cells (hiPSCs) offer novel approaches to study these complex diseases.

Purpose of the Study:

• To review the application of biosensor-based approaches and hiPSC-derived models in understanding DCM.
• To emphasize the importance of incorporating paracrine signaling in disease modeling.
• To discuss how these integrated approaches can inform patient-specific treatment strategies.

Main Methods:

• Utilizing biosensor-based approaches to study cellular signaling events in vitro and in vivo.
• Generating patient-derived hiPSC models to recapitulate individual cardiomyopathy phenotypes.
• Incorporating paracrine signaling mediators in multicellular culture systems.

Main Results:

• Biosensors enable real-time monitoring of signaling pathway dynamics in DCM models.
• hiPSC-derived cardiomyocytes provide patient-specific platforms for disease investigation.
• Multicellular models better reflect the complex cellular milieu and paracrine interactions in the heart.

Conclusions:

• The combination of biosensors and hiPSC technology offers powerful tools for dissecting DCM pathogenesis.
• Patient-derived models and advanced signaling analysis are key to developing personalized therapies for dilated cardiomyopathies.
• Future research should focus on integrating these advanced methodologies to accelerate therapeutic discovery for DCM.